We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current RAFA market cap is 6.1M. The company's latest EPS is USD 0.0031 and P/E is 22.58.
Year End December 30 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 11.44M | 74.73M | 77.41M | 64.31M | 10.14M |
Operating Income | 3.09M | 19.08M | 14.73M | 7.15M | 313k |
Net Income | 3.06M | 14.85M | 11.57M | 4.96M | 273k |
Year End December 30 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 20.53M | 70.63M | 89.34M | 98.32M | 12.13M |
Total Liabilities | 11.4M | 18.54M | 19.84M | 20.43M | 1.65M |
Total Equity | 9.13M | 52.1M | 69.51M | 77.89M | 10.47M |
Year End December 30 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 10.03M | -9.14M | 4.9M | 17.52M | -51.03M |
Investing | -9.34M | 7.96M | 6.86M | -11.73M | 32.9M |
Financing | 145k | 3.31M | -3.6M | -1.34M | 163k |
Market Cap | 6.1M |
Price to Earnings Ratio | 22.58 |
Price to Sales Ratio | 0.61 |
Price to Cash Ratio | 77.78 |
Price to Book Ratio | 0.59 |
Dividend Yield | - |
Shares Outstanding | 87.77M |
Average Volume (1 week) | 32.77k |
Average Volume (1 Month) | 23.6k |
52 Week Change | -75.18% |
52 Week High | 0.30 |
52 Week Low | 0.033 |
Spread (Intraday) | 0.05 (42.08%) |
Company Name | Rafarma Pharmaceuticals Inc (PK) |
Address |
203 s. main sheridan, wyoming 82801 |
Website | https://rafarma.si |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions